The Kirsten rat sarcoma viral oncogene homolog (RAS)/v-raf-1 murine leukemia viral
oncogene homolog 1 (RAF)/mitogen-activated protein kinase 1 (MAPK) signaling cascade is …

Thyroid cancer is the most common tumor arising from the endocrine system and generally
presents good prognosis. However, its aggressive subtypes are related to therapeutic …

In this study, we examined the relationship between coexisting BRAF V600E and TERT
promoter mutations in papillary thyroid cancer (PTC) and response to therapy. PTC cases …

Objective: Although the prognostic role of BRAFV600E mutation in papillary thyroid
carcinoma (PTC) is controversial, the American Thyroid Association (ATA) includes the …

Simple Summary Although papillary thyroid carcinoma (PTC) is generally a highly curable
disease, there is a small subgroup of PTC cases that behaves more aggressively, with high …

After the metabolic syndrome and its components, thyroid disorders represent the most
common endocrine disorders, with increasing prevalence in the last two decades. Thyroid …

Only a minority of cases of differentiated thyroid carcinoma (DTC) have a poor clinical
outcome. Clinical outcomes and molecular aspects were assessed in: 144 DTC≤ 40 mm …

Abstract Background The BRAF V600E gene encodes for the mutant BRAF V600E protein,
which triggers downstream oncogenic signaling in thyroid cancer. Since most currently …

Introduction The role of BRAF-activated non-protein coding RNA (BANCR) in papillary
thyroid carcinoma (PTC) is controversial, its clinical significance is unclear and no study has …

Background The primary goal of papillary thyroid cancer (PTC) management was to stratify
patients at pre-and post-surgical level to identify the small proportion of cases with …